The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats.
about
PPARs: Protectors or Opponents of Myocardial Function?PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic DrugsAVE8134, a novel potent PPARα agonist, improves lipid profile and glucose metabolism in dyslipidemic mice and type 2 diabetic rats.CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice.Astragaloside IV alleviates heart failure via activating PPARα to switch glycolysis to fatty acid β-oxidation.Whole grape intake impacts cardiac peroxisome proliferator-activated receptor and nuclear factor kappaB activity and cytokine expression in rats with diastolic dysfunction.Pharmacological PPARα activation markedly alters plasma turnover of the amino acids glycine, serine and arginine in the rat.Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.Cardiac dysfunction in adipose triglyceride lipase deficiency: treatment with a PPARα agonist.PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors.Enhancing the metabolic substrate: PPAR-alpha agonists in heart failure.Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies.Mitochondrial protein phosphorylation as a regulatory modality: implications for mitochondrial dysfunction in heart failure.Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure.Ligand specific variation in cardiac response to stimulation of peroxisome proliferator-activated receptor-alpha in spontaneously hypertensive rat.In vivo and in vitro protective effects of pentamethylquercetin on cardiac hypertrophy.A role for PPARα in the regulation of arginine metabolism and nitric oxide synthesis.Krüppel-like factors: Crippling and un-crippling metabolic pathways.
P2860
Q26771753-02E80850-DABF-4FB1-A75C-338C95C82243Q28066756-B0670BE8-61CC-434E-A095-2B270354DEF9Q33567011-91FD92D3-414F-40BE-B11C-1CA38C38BFB0Q33758242-A50F2C75-7EF9-4E9B-A0DE-07E3303FEED9Q33758755-05FC59AE-7DF8-42E9-AEEA-E68B7D400A0AQ34088823-44A17263-A098-4A27-9870-326F1356A425Q35499874-8610C801-2787-4DDA-BD1E-9159934224B3Q35636191-CC0DEDFA-F162-4E4C-9CF1-01728617D51CQ35708138-67A61E9E-2D47-4BE2-98B1-ABECA9ABFD87Q37719276-02669845-AA26-42F2-BA24-638DD6691787Q37812007-A659D9C1-4D16-4E5E-80FF-2AFC33D35EA6Q37835753-CB1A1664-7CA1-401E-B09E-3DD61ADA2B92Q37959068-F657279F-5C59-47C0-9575-CEA941FDCC3EQ47231445-DE931946-B3F8-4727-A520-6676FFF8F225Q48176436-3A2C1E2B-ECCA-4984-9807-3DA0A71E9BCAQ48766378-A6C43E1A-6978-42CE-8529-3B37BC7714B4Q53794886-73F62C68-AC1A-4191-8CFE-6A7E168F0145Q55079168-7607C19A-A0C2-4FA9-A323-67A1A706883C
P2860
The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The peroxisome proliferator-ac ...... nd increases survival in rats.
@ast
The peroxisome proliferator-ac ...... nd increases survival in rats.
@en
The peroxisome proliferator-ac ...... nd increases survival in rats.
@nl
type
label
The peroxisome proliferator-ac ...... nd increases survival in rats.
@ast
The peroxisome proliferator-ac ...... nd increases survival in rats.
@en
The peroxisome proliferator-ac ...... nd increases survival in rats.
@nl
prefLabel
The peroxisome proliferator-ac ...... nd increases survival in rats.
@ast
The peroxisome proliferator-ac ...... nd increases survival in rats.
@en
The peroxisome proliferator-ac ...... nd increases survival in rats.
@nl
P2093
P2860
P356
P1476
The peroxisome proliferator-ac ...... nd increases survival in rats.
@en
P2093
Eugen Falk
Hans-Ludwig Schäfer
Hartmut Rütten
Kristin Breitschopf
Manuel Baader
Martin Gerl
Paulus Wohlfart
Werner Kramer
Wolfgang Linz
P2860
P2888
P304
P356
10.1038/APS.2009.58
P577
2009-06-08T00:00:00Z
P5875
P6179
1052895319